Moderna Inc (MRNA)
53.54
-1.09
(-2.00%)
USD |
NASDAQ |
Nov 04, 16:00
53.54
0.00 (0.00%)
Pre-Market: 08:42
Moderna Cash from Financing (Quarterly): 34.00M for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 34.00M |
March 31, 2024 | 14.00M |
December 31, 2023 | -109.00M |
September 30, 2023 | -58.00M |
June 30, 2023 | -668.00M |
March 31, 2023 | -542.00M |
December 31, 2022 | -438.00M |
September 30, 2022 | -1.041B |
June 30, 2022 | -1.327B |
March 31, 2022 | -642.00M |
December 31, 2021 | -873.00M |
September 30, 2021 | -2.00M |
June 30, 2021 | -24.00M |
Date | Value |
---|---|
March 31, 2021 | 26.00M |
December 31, 2020 | 44.00M |
September 30, 2020 | 30.00M |
June 30, 2020 | 1.381B |
March 31, 2020 | 578.00M |
December 31, 2019 | 31.72M |
September 30, 2019 | 15.81M |
June 30, 2019 | 4.177M |
March 31, 2019 | 0.293M |
December 31, 2018 | 575.92M |
September 30, 2018 | -9.43M |
June 30, 2018 | 110.36M |
March 31, 2018 | 550.00M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.327B
Minimum
Jun 2022
1.381B
Maximum
Jun 2020
-188.70M
Average
-24.00M
Median
Jun 2021
Cash from Financing (Quarterly) Benchmarks
Eli Lilly and Co | 211.30M |
Merck & Co Inc | 1.216B |
Pfizer Inc | -2.459B |
Novavax Inc | 258.22M |
Amgen Inc | -3.651B |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -1.274B |
Cash from Investing (Quarterly) | 1.649B |
Free Cash Flow | -3.979B |
Free Cash Flow Per Share (Quarterly) | -3.792 |
Free Cash Flow to Equity (Quarterly) | -1.456B |
Free Cash Flow to Firm (Quarterly) | -1.456B |
Free Cash Flow Yield | -19.44% |